神经病理性疼痛药物的临床研究设计考虑要点  

The considerations for the clinical trials on drugs intended for the treatment of neuropathic pain

作　　者：耿莹[1] 赵德恒[2] 杨焕[2] 杨志敏[2] 

机构地区：[1]首都医科大学附属北京安定医院药物临床试验机构,北京100088 [2]国家食品药品监督管理总局药品审评中心,北京100038

出　　处：《中国临床药理学杂志》2014年第4期366-368,共3页The Chinese Journal of Clinical Pharmacology

摘　　要：神经病理性疼痛的治疗是全球性的医学难题,需要多学科参与,但药物治疗仍占据核心地位,研发安全有效的治疗药物是临床迫切需求。本文简要介绍研发神经病理性疼痛治疗药物的临床试验设计考虑要点,供制药企业和临床研究者参考。Neuropathic pain is one of the global medical difficulties , and it requires a multidisciplinary participation , but the core method still is the drug.To develop safe and effective drugs intended for the treatment of neuropathic pain is very important for clinical treatment.This article introduces considerations for the clinical trial designs of developing drugs intended for the treatment of neuropathic pain , offering helps for pharma-ceutical enteprises and clinical investigators.

关 键 词：神经病理性疼痛 药物临床试验 

分 类 号：R441.1[医药卫生—诊断学] R969.4[医药卫生—临床医学]